TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.

Luis Paz-Ares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.